|
Re: New Apabetalone Clinical Trial for Pulmonary Arterial Hypertension
|
2
|
Resverlogix Corp.
|
Jun 05, 2019 02:06PM
|
|
Medimmune fusion proteins described in Q2 update
|
2
|
BIOASIS TECHNOLOGIES INC
|
Aug 02, 2016 11:50AM
|
|
Re: News - August 29
|
2
|
BIOASIS TECHNOLOGIES INC
|
Aug 30, 2016 11:13AM
|
|
FSHD- Acceleron’s ACE-083 Therapy Candidate
|
2
|
Resverlogix Corp.
|
May 07, 2018 01:58PM
|
|
Re: Denali/Sirion deal to get AAVs across the BBB
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jan 10, 2019 10:18AM
|
|
Re: Opportunity Knocks
|
2
|
Resverlogix Corp.
|
Jul 20, 2019 08:18AM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
2
|
Resverlogix Corp.
|
Mar 26, 2020 03:39PM
|
|
Re: Jardiance??
|
2
|
Resverlogix Corp.
|
Oct 17, 2018 09:49AM
|
|
Re: New patent application - USA Inventor
|
2
|
Resverlogix Corp.
|
May 08, 2017 05:07PM
|
|
Re: Little help? Short interest
|
2
|
Resverlogix Corp.
|
Feb 06, 2019 11:59AM
|
|
Re: ZEN-3694 Single Agent Trial Status
|
2
|
Zenith Epigenetics
|
Jan 16, 2018 08:42PM
|
|
Re: Top-line vs. Full Detailed Clinical Trial Results
|
2
|
Resverlogix Corp.
|
Dec 07, 2018 02:52PM
|
|
Re: Zenith Announces Issuance of Patent for ZEN-3694 and Presentation Details at BIO International Convention
|
2
|
Zenith Epigenetics
|
Jun 06, 2017 10:09AM
|
|
Bioasis Strengthens Senior Management Team with Appointment of Caroline Dircks, Ph.D. as Chief Operating Officer
|
2
|
BIOASIS TECHNOLOGIES INC
|
Aug 16, 2019 06:53AM
|
|
Re: Resverlogix Announces Annual and Special Meeting of Shareholders
|
2
|
Resverlogix Corp.
|
Oct 07, 2016 08:56AM
|
|
Re: Comments re AHA presentation
|
2
|
Resverlogix Corp.
|
Nov 16, 2019 10:43PM
|
|
Re: AGM Notice
|
2
|
Resverlogix Corp.
|
Nov 03, 2016 12:56PM
|
|
Re: Zacks SCR Resverlogix Report 12/16/16
|
2
|
Resverlogix Corp.
|
Dec 20, 2016 10:44AM
|
|
Re: What now
|
2
|
Zenith Epigenetics
|
Jun 13, 2017 01:26PM
|
|
Re: European Atherosclerosis Society 2019 meeting May 26-29
|
2
|
Resverlogix Corp.
|
May 20, 2019 03:57PM
|
